169 related articles for article (PubMed ID: 28077240)
1. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.
Zongo FE; Moisan J; Grégoire JP; Lesage A; Dossa AR; Lauzier S
Res Social Adm Pharm; 2018 Jan; 14(1):53-61. PubMed ID: 28077240
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacy loyalty among individuals with schizophrenia.
Lauzier S; Grégoire JP; Lesage A; Moisan J
Res Social Adm Pharm; 2013; 9(6):806-16. PubMed ID: 23522802
[TBL] [Abstract][Full Text] [Related]
3. Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study.
Dossa AR; Grégoire JP; Lauzier S; Guénette L; Sirois C; Moisan J
Medicine (Baltimore); 2015 Jul; 94(27):e1082. PubMed ID: 26166087
[TBL] [Abstract][Full Text] [Related]
4. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.
Evans CD; Eurich DT; Lamb DA; Taylor JG; Jorgenson DJ; Semchuk WM; Mansell KD; Blackburn DF
J Manag Care Pharm; 2009; 15(6):476-84. PubMed ID: 19610680
[TBL] [Abstract][Full Text] [Related]
5. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
Jiang Y; Ni W
Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
[TBL] [Abstract][Full Text] [Related]
6. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
Winslade N; Tamblyn R
BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
[TBL] [Abstract][Full Text] [Related]
7. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
8. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
[TBL] [Abstract][Full Text] [Related]
9. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
10. Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients.
Polinski JM; Schneeweiss S; Levin R; Shrank WH
Clin Ther; 2009 Sep; 31(9):2048-59. PubMed ID: 19843494
[TBL] [Abstract][Full Text] [Related]
11. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacy transition of care services and rural hospital readmissions: A case study.
Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
[TBL] [Abstract][Full Text] [Related]
13. The missing path to gain customers loyalty in pharmacy retail: The role of the store in developing satisfaction and trust.
Castaldo S; Grosso M; Mallarini E; Rindone M
Res Social Adm Pharm; 2016; 12(5):699-712. PubMed ID: 27555108
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.
Cyr MC; Beauchense MF; Lemiere C; Blais L
J Popul Ther Clin Pharmacol; 2013; 20(1):e26-41. PubMed ID: 23392860
[TBL] [Abstract][Full Text] [Related]
16. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.
Cooper D; Moisan J; Grégoire JP
J Clin Psychiatry; 2007 Jun; 68(6):818-25. PubMed ID: 17592904
[TBL] [Abstract][Full Text] [Related]
17. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
19. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.
Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L
Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647
[TBL] [Abstract][Full Text] [Related]
20. Community pharmacy services in the United Arab Emirates.
Hasan S; Sulieman H; Chapman CB; Stewart K; Kong DC
Int J Pharm Pract; 2012 Aug; 20(4):218-25. PubMed ID: 22775518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
